88 related articles for article (PubMed ID: 11997200)
1. Death rattle: prevalence, prevention and treatment.
Wildiers H; Menten J
J Pain Symptom Manage; 2002 Apr; 23(4):310-7. PubMed ID: 11997200
[TBL] [Abstract][Full Text] [Related]
2. Death rattle: current experiences and non-pharmacological management-a narrative review.
Moons L; De Roo ML; Deschodt M; Oldenburger E
Ann Palliat Med; 2024 Jan; 13(1):150-161. PubMed ID: 38073292
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic drugs for death rattle in dying patients with cancer: multicentre prospective cohort study.
Yamaguchi T; Yokomichi N; Yamaguchi T; Maeda I; Matsunuma R; Tanaka-Yagi Y; Akatani A; Suzuki K; Kohara H; Taniyama T; Matsuda Y; Nakajima N; Morita T; Tsuneto S; Mori M
BMJ Support Palliat Care; 2023 Dec; 13(4):462-471. PubMed ID: 36357162
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of audible upper airway secretions ("death rattle") in patients with cancer in the last days of life.
Davies A; Waghorn M; Skene S
Support Care Cancer; 2024 Jun; 32(7):423. PubMed ID: 38862857
[TBL] [Abstract][Full Text] [Related]
5. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient.
Murphy D; Waldron D; Kennedy G; Molony J
BMJ Support Palliat Care; 2024 Jan; 13(e3):e953-e956. PubMed ID: 36379687
[TBL] [Abstract][Full Text] [Related]
6. Reducing death rattle at the end of life.
Potter J; Korownyk CS
Can Fam Physician; 2023 Jul; 69(7):477. PubMed ID: 37451996
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Should (Prophylactic) Medications Be Used for the Management of Death Rattle?" J Pain Symptom Manage 2023;66:e513-e517.
van Esch HJ; Campbell ML; Mori M; Yamaguchi T
J Pain Symptom Manage; 2024 Jun; ():. PubMed ID: 38878028
[No Abstract] [Full Text] [Related]
8. Dr. Dowler on Death.
West J Med Surg; 1850 Jun; 5(6):545-548. PubMed ID: 38209752
[No Abstract] [Full Text] [Related]
9. Death of Dr. Zagorsky.
West J Med Surg; 1849 May; 3(5):449. PubMed ID: 38209562
[No Abstract] [Full Text] [Related]
10. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
[TBL] [Abstract][Full Text] [Related]
11. Interventions for noisy breathing in patients near to death.
Wee B; Hillier R
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD005177. PubMed ID: 18254072
[TBL] [Abstract][Full Text] [Related]
12. Management of death rattle at end of life.
Twomey S; Dowling M
Br J Nurs; 2013 Jan 24-Feb 13; 22(2):81-5. PubMed ID: 23587890
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, impact, and treatment of death rattle: a systematic review.
Lokker ME; van Zuylen L; van der Rijt CC; van der Heide A
J Pain Symptom Manage; 2014 Jan; 47(1):105-22. PubMed ID: 23790419
[TBL] [Abstract][Full Text] [Related]
14. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.
Back IN; Jenkins K; Blower A; Beckhelling J
Palliat Med; 2001 Jul; 15(4):329-36. PubMed ID: 12054150
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of glycopyrronium bromide and scopolamine hydrobromide in patients with death rattle: a randomized controlled study].
Likar R; Rupacher E; Kager H; Molnar M; Pipam W; Sittl R
Wien Klin Wochenschr; 2008; 120(21-22):679-83. PubMed ID: 19116709
[TBL] [Abstract][Full Text] [Related]
16. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life.
Clark K; Currow DC; Agar M; Fazekas BS; Abernethy AP
J Pain Palliat Care Pharmacother; 2008; 22(2):131-8. PubMed ID: 19042837
[TBL] [Abstract][Full Text] [Related]
17. Respiratory tract secretions in the dying patient: a retrospective study.
Kåss RM; Ellershaw J
J Pain Symptom Manage; 2003 Oct; 26(4):897-902. PubMed ID: 14527758
[TBL] [Abstract][Full Text] [Related]
18. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care.
Bennett M; Lucas V; Brennan M; Hughes A; O'Donnell V; Wee B;
Palliat Med; 2002 Sep; 16(5):369-74. PubMed ID: 12380654
[TBL] [Abstract][Full Text] [Related]
19. Hyoscine vs glycopyrronium for drying respiratory secretions in dying patients.
Lawrey H
Br J Community Nurs; 2005 Sep; 10(9):421-4, 426. PubMed ID: 16234752
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and narrative summary: Treatments for and risk factors associated with respiratory tract secretions (death rattle) in the dying adult.
Kolb H; Snowden A; Stevens E
J Adv Nurs; 2018 Jul; 74(7):1446-1462. PubMed ID: 29495089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
